Limited OXPHOS capacity in white adipocytes is a hallmark of obesity in laboratory mice irrespective of the glucose tolerance status

Molecular Metabolism

Volumn 4, Issue 9, 2015, Pages 631-642

  Schöttl, Theresa ^a   Kappler, Lisa ^a   Fromme, Tobias ^a   Klingenspor, Martin ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Glucose tolerance; Mitochondria; Obesity; White adipocyte metabolism

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ENERGY; CELL RESPIRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIDIDYMIS FAT; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; IMPAIRED GLUCOSE TOLERANCE; INTRAABDOMINAL FAT; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIROMETRY; SUBCUTANEOUS FAT; WHITE ADIPOCYTE;

MURINAE; MUS; RODENTIA;

EID: 84940438529     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.07.001     Document Type: Article

References (40)

1. Elia M. Organ and tissue contribution to metabolic rate. Energy metabolism: tissue determinants and cellular corollaries 1992, 61-80. Raven Press, New York. J. Kinney, H. Tucker (Eds.).
2. Wang Z., Ying Z., Bosy-Westphal A., Zhang J., Schautz B., Later W., et al. Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure. American Journal of Clinical Nutrition 2010, 92(6):1369-1377.
3. Kaiyala K.J., Morton G.J., Leroux B.G., Ogimoto K., Wisse B., Schwartz M.W. Identification of body fat mass as a major determinant of metabolic rate in mice. Diabetes 2010, 59(7):1657-1666.
4. Brand M.D., Nicholls D.G. Assessing mitochondrial dysfunction in cells. Biochemical Journal 2011, 435(2):297-312.
5. Stehling O., Wilbrecht C., Lill R. Mitochondrial iron-sulfur protein biogenesis and human disease. Biochimie 2014, 100:61-77.
6. De Pauw A., Tejerina S., Raes M., Keijer J., Arnould T. Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. American Journal of Pathology 2009, 175(3):927-939.
7. Koh E.H., Park J.Y., Park H.S., Jeon M.J., Ryu J.W., Kim M., et al. Essential role of mitochondrial function in adiponectin synthesis in adipocytes. Diabetes 2007, 56(12):2973-2981.
8. 2 consumption of human adipose tissue. American Journal of Physiology 1989, 256(4 Pt 1):E467-E474.
9. Choo H.J., Kim J.H., Kwon O.B., Lee C.S., Mun J.Y., Han S.S., et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 2006, 49(4):784-791.
10. Rong J.X., Qiu Y., Hansen M.K., Zhu L., Zhang V., Xie M., et al. Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 2007, 56(7):1751-1760.
11. Valerio A., Cardile A., Cozzi V., Bracale R., Tedesco L., Pisconti A., et al. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. Journal of Clinical Investigation 2006, 116(10):2791-2798.
12. Wilson-Fritch L., Nicoloro S., Chouinard M., Lazar M.A., Chui P.C., Leszyk J., et al. Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. Journal of Clinical Investigation 2004, 114(9):1281-1289.
13. Dahlman I., Forsgren M., Sjogren A., Nordstrom E.A., Kaaman M., Naslund E., et al. Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-alpha. Diabetes 2006, 55(6):1792-1799.
14. Schottl T., Kappler L., Braun K., Fromme T., Klingenspor M. Limited mitochondrial capacity of visceral versus subcutaneous white adipocytes in male C57BL/6N mice. Endocrinology 2014, en20141689.
15. Fellmann L., Nascimento A.R., Tibirica E., Bousquet P. Murine models for pharmacological studies of the metabolic syndrome. Pharmacology & Therapeutics 2013, 137(3):331-340.
16. Bolze F., Rink N., Brumm H., Kuhn R., Mocek S., Schwarz A.E., et al. Characterization of the melanocortin-4-receptor nonsense mutation W16X in vitro and in vivo. Pharmacogenomics Journal 2013, 13(1):80-93.
17. Even P.C., Nadkarni N.A. Indirect calorimetry in laboratory mice and rats: principles, practical considerations, interpretation and perspectives. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2012, 303(5):R459-R476.
18. Boudina S., Sena S., O'Neill B.T., Tathireddy P., Young M.E., Abel E.D. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005, 112(17):2686-2695.
19. Wang P.W., Kuo H.M., Huang H.T., Chang A.Y., Weng S.W., Tai M.H., et al. Biphasic response of mitochondrial biogenesis to oxidative stress in visceral fat of diet-induced obesity mice. Antioxidants & Redox Signaling 2014.
20. Loschen G., Azzi A., Richter C., Flohe L. Superoxide radicals as precursors of mitochondrial hydrogen peroxide. FEBS Letters 1974, 42(1):68-72.
21. Loschen G., Azzi A. On the formation of hydrogen peroxide and oxygen radicals in heart mitochondria. Recent Advances in Studies on Cardiac Structure and Metabolism 1975, 7:3-12.
22. Treberg J.R., Quinlan C.L., Brand M.D. Hydrogen peroxide efflux from muscle mitochondria underestimates matrix superoxide production - a correction using glutathione depletion. FEBS Journal 2010, 277(13):2766-2778.
23. Kless C., Klingenspor M. Metabolic status of adipocytes triggers rapid adjustments of systemic glucose tolerance. FASEB Journal 2013, 27. (1071.2).
24. Ryu M.J., Kim S.J., Kim Y.K., Choi M.J., Tadi S., Lee M.H., et al. Crif1 deficiency reduces adipose OXPHOS capacity and triggers inflammation and insulin resistance in mice. PLoS Genetics 2013, 9(3):e1003356.
25. Keuper M., Jastroch M., Yi C.X., Fischer-Posovszky P., Wabitsch M., Tschop M.H., et al. Spare mitochondrial respiratory capacity permits human adipocytes to maintain ATP homeostasis under hypoglycemic conditions. FASEB Journal 2014, 28(2):761-770.
26. Kusminski C.M., Scherer P.E. Mitochondrial dysfunction in white adipose tissue. Trends in Endocrinology Metabolism 2012, 23(9):435-443.
27. 2 consumption triggers HIF-1alpha, causing inflammation and insulin resistance in obesity. Cell 2014, 157(6):1339-1352.
28. Ye J., Gao Z., Yin J., He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. American Journal of Physiology, Endocrinology and Metabolism 2007, 293(4):E1118-E1128.
29. Rausch M.E., Weisberg S., Vardhana P., Tortoriello D.V. Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. International Journal of Obesity (London) 2008, 32(3):451-463.
30. Choi S., Cho K., Kim J., Yea K., Park G., Lee J., et al. Comparative proteome analysis using amine-reactive isobaric tagging reagents coupled with 2D LC/MS/MS in 3T3-L1 adipocytes following hypoxia or normoxia. Biochemical and Biophysical Research Communications 2009, 383(1):135-140.
31. Perez de Heredia F., Wood I.S., Trayhurn P. Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, and MCT4) expression in human adipocytes. Pflugers Archiv 2010, 459(3):509-518.
32. Wood I.S., Wang B., Lorente-Cebrian S., Trayhurn P. Hypoxia increases expression of selective facilitative glucose transporters (GLUT) and 2-deoxy-D-glucose uptake in human adipocytes. Biochemical and Biophysical Research Communications 2007, 361(2):468-473.
33. Trayhurn P., Alomar S.Y. Oxygen deprivation and the cellular response to hypoxia in adipocytes - perspectives on white and brown adipose tissues in obesity. Frontiers in Endocrinology (Lausanne) 2015, 6:19.
34. Geiger K., Leiherer A., Muendlein A., Stark N., Geller-Rhomberg S., Saely C.H., et al. Identification of hypoxia-induced genes in human SGBS adipocytes by microarray analysis. PLoS One 2011, 6(10):e26465.
35. Diraison F., Dusserre E., Vidal H., Sothier M., Beylot M. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. American Journal of Physiology, Endocrinology Metabolism 2002, 282(1):E46-E51.
36. Vida M., Rivera P., Gavito A.L., Suarez J., Pavon F.J., Arrabal S., et al. CB1 blockade potentiates down-regulation of lipogenic gene expression in perirenal adipose tissue in high carbohydrate diet-induced obesity. PLoS One 2014, 9(2):e90016.
37. Ortega F.J., Mayas D., Moreno-Navarrete J.M., Catalan V., Gomez-Ambrosi J., Esteve E., et al. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) 2010, 18(1):13-20.
38. O'Rourke R.W., Meyer K.A., Gaston G., White A.E., Lumeng C.N., Marks D.L. Hexosamine biosynthesis is a possible mechanism underlying hypoxia's effects on lipid metabolism in human adipocytes. PLoS One 2013, 8(8):e71165.
39. Yin X., Lanza I.R., Swain J.M., Sarr M.G., Nair K.S., Jensen M.D. Adipocyte mitochondrial function is reduced in human obesity independent of fat cell size. Journal of Clinical Endocrinology and Metabolism 2013, jc20133042.
40. Derous D., Kelder T., van Schothorst E.M., van Erk M., Voigt A., Klaus S., et al. Network-based integration of molecular and physiological data elucidates regulatory mechanisms underlying adaptation to high-fat diet. Genes Nutrition 2015, 10(4):470.